Quorum Review IRB and Kinetiq to Celebrate eConsent Product Launch, Present Sessions at DIA 2017

Launch of IRB-integrated eConsent solution and informative presentations at DIA 2017 highlight industry-leading impact of Quorum and Kinetiq on the global clinical research community

News provided by

Quorum Review IRB

Jun 15, 2017, 13:02 ET

SEATTLE, June 15, 2017 /PRNewswire/ -- Quorum Review IRB will celebrate the launch of Q Consent™, the new standard in electronic informed consent, at DIA 2017 in booth #2212. Kinetiq, the consulting and technology division of Quorum, also will be featured in two sessions at next week's DIA conference with topics that range from emerging trends to best practices in clinical research.

Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subject protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies—as well as others around the world—to develop contemporary approaches to a changing landscape.
Kinetiq is a consulting and technology division of Quorum that delivers innovative solutions to the challenges of human subject protections and compliance in clinical research. Kinetiq works with clinical researchers, research institutions, pharmaceutical, biotechnology, and medical device companies—as well as others around the world—to develop contemporary approaches to a changing landscape.

"As always, we look forward to presenting our subject matter expertise on topics that positively impact the clinical research community," says Quorum CEO Cami Gearhart. "Our mission at Quorum is to move research forward together, and our Q Consent tool will help researchers and sponsors move forward with a new standard in consenting. We invite DIA attendees to visit us, celebrate our launch, and find out why secure electronic informed consent is now easy and affordable."

Breakout Sessions

Kinetiq Regulatory Attorney Aarthi B. Iyer will present regulatory insights in an informative session on postmarketing safety studies. Study sponsors and CROs will learn how to maximize the impact of postmarketing studies and achieve effective execution and compliance. This session takes place on Monday, June 19 at 11:00 a.m.

James Riddle, Vice President of Client Services for Kinetiq, will be featured in a breakout session, where he and representatives from HHS will discuss the new Common Rule and its impact on sponsors and CROs. This session is scheduled for Wednesday, June 21 at 2:00 p.m.

Celebrate Q Consent

Visit Quorum and Kinetiq in the exhibit hall on Monday, June 19 at 4:45 p.m. at booth 2212, where Quorum will host a champagne toast to celebrate the launch of the revolutionary eConsent solution: Q Consent.

About Quorum Review IRB
Discover more at our website.

About Kinetiq
Discover more at our website.

Contact:

Scott Smith
Director of Marketing
(206) 448-4082
[email protected]


SOURCE Quorum Review IRB